Targeting murine alveolar macrophages by the intratracheal administration of locked nucleic acid containing antisense oligonucleotides

The pulmonary delivery of locked nucleic acid containing antisense oligonucleotides (LNA-ASOs) is expected to be a novel therapeutic approach for lung diseases. However, there are two concerns to be considered: immune responses, as the lung has a distinct immune mechanism to protect it from inhaled...

Descripción completa

Detalles Bibliográficos
Autores principales: Uemura, Yasunori, Kobayashi, Katsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713109/
https://www.ncbi.nlm.nih.gov/pubmed/31385541
http://dx.doi.org/10.1080/10717544.2019.1648589

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713109/
https://www.ncbi.nlm.nih.gov/pubmed/31385541
http://dx.doi.org/10.1080/10717544.2019.1648589

Ejemplares similares